Description
Myfortic is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants. Treatment with Myfortic should be initiated and maintained by appropriately qualified transplant specialists.
Additional information
| brand | Novartis Pharmaceuticals |
|---|
